The global peripheral vascular devices market, valued at USD 4.7 billion in 2022, is projected to expand at a robust CAGR of 6.6%, reaching USD 8.9 billion by 2032, according to Future Market Insights ...

R3 Vascular announced that a doctor treated the first patient in the ELITE-BTK pivotal trial of its drug-eluting ...

The initial long-term results from EFEMORAL I were presented today by Principal Investigator Prof. Andrew Holden (Auckland ...

Peripheral vascular devices are critical in the treatment of peripheral vascular ... thereby increasing the number of patients requiring medical interventions and driving market growth. Despite these ...

Semler Scientific has offered to pay the Department of Justice nearly $30 million to settle federal health care fraud claims ...

Limus-based devices, rather than being a substitute for paclitaxel as they were once seen, are coming of age in peripheral ...

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the commercial release of the Pounce™ XL ...

Efemoral Medical announced the presentation of long-term results from the initial 20 patients enrolled across four sites in ...

With its remote endovascular procedure system currently under review at the FDA, Microbot Medical has put forward positive ...

Analysts expect Penumbra to report an earnings per share (EPS) of $0.67. The announcement from Penumbra is eagerly ...